GLP-1 drugs may improve fertility and prevent pregnancy loss through immune, vascular, and metabolic mechanisms | Research

The takeaway

GLP-1 receptor agonists improve obesity-related infertility and recurrent pregnancy loss through macrophage polarization, Treg enhancement, pro-inflammatory cytokine suppression, improved vascularization, and reduced oxidative stress—though pregnancy use remains contraindicated.

Immune + metabolic fertility boost
GLP-1 drugs improve fertility through multiple immune mechanisms (Tregs, macrophage polarization, anti-inflammation) beyond just weight loss—but remain contraindicated during pregnancy

What the researchers found

GLP-1RAs improve fertility through: macrophage M2 polarization, ↓pro-inflammatory cytokines, ↑Treg activity, improved vascularization, ↓oxidative stress. Weight loss enhances insulin sensitivity and endocrine balance. Contraindicated during pregnancy. Preconception protocols promising.

Why it matters

Obesity-related infertility affects millions of women. Understanding that GLP-1 drugs improve fertility through immune mechanisms—not just weight loss—provides rationale for preconception GLP-1 therapy.

How the study worked

Narrative review of GLP-1RA immunological and metabolic effects relevant to reproduction.

What this study cannot tell us

Review format. No clinical trials of GLP-1 drugs specifically for infertility. Pregnancy contraindication limits clinical translation. Immune mechanisms extrapolated from non-reproductive studies.

How to read the evidence

Narrative review of mechanistic evidence. Strong biological rationale needing clinical validation.

When this study was published

Published in 2025.

The bigger picture

GLP-1 drugs' immune-modulating effects may be as important as their metabolic effects for fertility. This positions them as multi-mechanism preconception agents for obese women planning pregnancy.

Questions still open

Should preconception GLP-1 therapy become standard for obese infertile women?
How long before conception should GLP-1 drugs be stopped?
Could GLP-1 drugs safely be used in early pregnancy?

Common questions

Can GLP-1 drugs help with getting pregnant?

Research suggests GLP-1 drugs may improve fertility in obese women through multiple mechanisms beyond weight loss: reducing inflammation, enhancing immune tolerance needed for pregnancy, improving blood flow to the uterus, and reducing oxidative stress. However, they must be stopped before becoming pregnant.

Can you take GLP-1 drugs during pregnancy?

No—GLP-1 drugs are currently contraindicated during pregnancy due to insufficient safety data. However, taking them before conception to improve weight, inflammation, and immune function may enhance fertility outcomes. The manufacturer recommends stopping at least 2 months before planned conception.

Read the original research

Immunological effects of GLP-1 analogs on female reproduction: Therapeutic perspectives for infertility and recurrent pregnancy loss.

Journal of reproductive immunology, 169, 104538

View on PubMed ↗Publisher’s paper ↗

Citation

Tavares, Ana Clara Muniz; Martins, Maria Yzadora Moura; de Souza, Giselle Ferreira; Lima, Eduarda Maia; Rocha, Camila Alves; de Souza, Larissa Cruz; Simões, Júlia Machado Luz; de Araújo, Nicole Oliveira; Cavalcante, Marcelo Borges. (2025). Immunological effects of GLP-1 analogs on female reproduction: Therapeutic perspectives for infertility and recurrent pregnancy loss.. Journal of reproductive immunology, 169, 104538. https://doi.org/10.1016/j.jri.2025.104538